NCT07167784

Brief Summary

Chronic inflammatory rheumatic diseases (IRDs), such as rheumatoid arthritis and spondyloarthritis, can cause pain, fatigue, and mobility issues, significantly impacting patients' quality of life. Physical activity is an important part of managing these conditions, as it helps reduce pain, maintain mobility, and prevent complications. However, many patients struggle to stay active due to pain and fatigue. A better understanding of these challenges could lead to improved support and interventions. This study explores a new way to monitor the daily experiences of patients with IRDs using Ecological Momentary Assessment (EMA), a method that collects real-time data through a mobile app. The study will also use actimeters-wearable devices that track physical activity. Over 14 days, participants will answer short surveys on their phones and wear an actimeter to provide insights into how fatigue, pain, mood, and physical activity levels change throughout the day. Before this approach is implemented in a larger study, its practicality and acceptability for patients must be evaluated. This pilot study will assess whether participants find the mobile app and actimeter easy to use, how often surveys are completed, and whether frequent reminders affect participants' willingness to continue. The study will also examine the immediate and delayed effects of different symptoms on physical activity and explore factors that influence participant engagement with the protocol. By identifying potential barriers and solutions, this research will help refine future studies and improve methods for monitoring and supporting individuals with IRDs in staying active while managing symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 11, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 24, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2026

Completed
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

September 3, 2025

Last Update Submit

April 16, 2026

Conditions

Keywords

Ecological Momentary AssessmentChronic Inflammatory Rheumatic Diseasesphysical activityfatiguesleeppainactigraphy

Outcome Measures

Primary Outcomes (2)

  • Feasibility of a 14-day smartphone EMA protocol combined with actigraphy

    Feasibility will be quantified on five pre-specified indicators: (1) attrition rates; measured by the number of participants who withdrew from the study, (2) the number and percentage of data collected from EMA surveys relative to the number of potential assessments, (3) the percentage of surveys that a participant started to complete, relative to the number of potential assessments, (4) time elapsed between the prompt and the start of the response to the survey, (5) adherence to actigraphy (the threshold is at least 21 hours of wear time over 24 hours, for 14 days).

    Day 1 to Day 14 after enrollment

  • Acceptability of a 14-day EMA protocol combined with actigraphy delivered via a mobile application

    Acceptability will be assessed at follow-up using a structured questionnaire and semi-structured interviews. The questionnaire will evaluate participant satisfaction, perceived relevance, ease of use, and daily burden associated with EMA and actigraphy. Each item will be rated on a five-point Likert scale (1 = strongly disagree to 5 = strongly agree). Acceptability at the item level will be defined as ≥70% agreement on positively worded items and ≤30% agreement on negatively worded items. A score ≥3/5 will indicate acceptable validation of an item. In addition, semi-structured interviews will be conducted to explore participant experiences; with consent, sessions will be audio-recorded, transcribed in a non-verbatim format, and analyzed using content analysis to identify recurring themes.

    Day 1 to Day 14 after enrollment

Secondary Outcomes (4)

  • Immediate and Lagged Effects on Physical Activity

    Day 1 to Day 14 after enrollment

  • Immediate and Lagged Effects of Determinants on Physical Activity

    Day 1 to Day 14 after enrollment

  • Adherence and Acceptability of Two Actigraph Devices

    Day 1 to Day 14 after enrollment

  • Patient-Perceived Acceptability

    Day 1 to Day 14 after enrollment

Interventions

Participants will be complete four daily EMA surveys via the Avicenna Research app (morning, 11 a.m., 3 p.m., and evening). Participants will be instructed to complete and submit each survey as soon as they see the app notification. If no response is provided within 15 minutes, a reminder notification will be sent. At the end of the 14-day period, devices will be returned using a prepaid envelope provided by the study team and participants will complete an end-of-study questionnaire to assess the acceptability of the study and will be invited to participate in a debriefing interview with a member of the research team.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults diagnosed with Chronic inflammatory rheumatic diseases (rheumatoid arthritis or spondyloarthritis)

You may qualify if:

  • Adults able to understand and consent to the study protocol,
  • Adults affiliated with a social security system
  • Adults that have access to a digital device with internet access (e.g., smartphone or tablet).
  • Insufficient proficiency in the French language
  • Legal incapacity or deprivation of liberty
  • Major cognitive impairment incompatible with repeated questionnaire completion (e.g., Alzheimer's disease)
  • Pregnant or breastfeeding women
  • Individuals with a history of alcohol or substance abuse, or severe psychiatric disorders that could affect adherence to the protocol or the reliability of collected data, are also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Grenoble Alpes

Grenoble, France, 38000, France

Location

Related Publications (1)

  • Aymard N, Darmaillacq A, Bailly S, Kechichian A, Baillieul S, Bernardy C, Gastaldi R, Flore P, Baillet A, Mendelson M. Ecological momentary assessment of daily patient-reported outcomes and actigraphy-measured physical activity and sleep in patients with rheumatoid arthritis and spondyloarthritis: a study protocol. BMJ Open. 2026 Feb 10;16(2):e113370. doi: 10.1136/bmjopen-2025-113370.

MeSH Terms

Conditions

SpondylarthritisArthritis, RheumatoidMotor ActivityFatiguePain

Interventions

Ecological Momentary Assessment

Condition Hierarchy (Ancestors)

SpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesArthritisJoint DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBehaviorSigns and SymptomsPathological Conditions, Signs and SymptomsNeurologic Manifestations

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2025

First Posted

September 11, 2025

Study Start

November 24, 2025

Primary Completion

April 3, 2026

Study Completion

April 3, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) that underlie the results reported in this study will be made available.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data will become available 6 months after publication of the main results and will remain available for 5 years.
Access Criteria
Data will be available to researchers who provide a methodologically sound proposal. Requests should be directed to the study coordinator. After approval of the proposal, data will be shared via a secure repository or direct data transfer agreement.

Locations